Sam Chun Dang Pharm Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Dae-In Yoon
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 7.1% |
| Management average tenure | no data |
| Board average tenure | no data |
Recent management updates
Recent updates
Optimistic Investors Push Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Shares Up 28% But Growth Is Lacking
Mar 21
Sam Chun Dang Pharm (KOSDAQ:000250) Seems To Use Debt Quite Sensibly
Feb 26Investors Who Bought Sam Chun Dang Pharm (KOSDAQ:000250) Shares Five Years Ago Are Now Up 644%
Feb 09Could The Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Ownership Structure Tell Us Something Useful?
Jan 05
Here's Why Sam Chun Dang Pharm (KOSDAQ:000250) Can Manage Its Debt Responsibly
Dec 01CEO
Dae-In Yoon (73 yo)
no data
Tenure
Dae-In Yoon serves as the Chief Executive Officer and Chairman of Sam Chun Dang Pharmacy. Dae-In Yoon serves as Chief Executive Officer and Chairperson of Sam Chun Dang Pharm Co. Ltd. Dae-In Yoon serves as...